Current research indicates that TRIM28 is a target gene for WDR4, and high TRIM28 expression is significantly associated with cell-acquired stemness and lenvatinib resistance in HCC (Han et al., 2023). The gene discussed is TRIM28; the disease is hepatocellular carcinoma.